C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/64 (2006.01) A61K 38/48 (2006.01) C12N 15/57 (2006.01) C07K 14/745 (2006.01)
Patent
CA 2721683
Disclosed are modified Factor IX polypeptides such as Factor IX polypeptides with one or more introduced glycosylation sites. The modified Factor IX polypeptides may exhibit increased in vitro or in vivo stability such as a longer plasma half- life. Also, methods are disclosed of making modified Factor IX polypeptides, and methods of using modified Factor IX polypeptides, for example, to treat patients afflicted with hemophilia B.
La présente invention concerne des polypeptides modifiés de facteur IX tels que des polypeptides de facteur IX avec un ou des sites de glycosylation introduits. Les polypeptides modifiés de facteur IX peuvent présenter une stabilité accrue in vitro ou in vivo telle quune demi-vie plasmatique plus longue. Linvention concerne également des procédés de fabrication de polypeptides modifiés de facteur IX, et des procédés dutilisation de polypeptides modifiés de facteur IX, par exemple, pour traiter des patients atteints de lhémophilie B.
Brooks Alan
Gritzan Uwe
Haupts Ulrich
Jiang Xiaoqiao
Kirchner Kornelia
Bayer Healthcare Llc
Bayer Schering Pharma Aktiengesellschaft
Mbm Intellectual Property Law Llp
LandOfFree
Modified factor ix polypeptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified factor ix polypeptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified factor ix polypeptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486272